← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2004Last known activity
Dec 31, 2025
Timeline
1980s
- Jun 1, 1983
Celldex Therapeutics— Founded
2000s
- Oct 12, 2005
Alteris Therapeutics— Acquired
- Nov 1, 2005
Lorantis— Acquired
- Jan 1, 2008
Avant Immunotherapeutics— Acquired
- Jan 1, 2009
CuraGen— Acquired
2010s
- Nov 1, 2016
Kolltan Pharmaceuticals— Acquired
Drugs by trial phase (48 distinct, 71 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (20 own, 7 via acquisition)
Phase 1 (16 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Clear Cell
- Adenomyoepithelioma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Cholangiocarcinoma
- Colorectal Neoplasms
- Fallopian Tube Neoplasms
- Glioblastoma
- Glioma
- Gliosarcoma
- Glomerulonephritis
- Glomerulonephritis, Membranoproliferative
- Head and Neck Neoplasms
- Hodgkin Disease
- Kidney Diseases
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Melanoma
- Myelodysplastic Syndromes
- Neoplasms
- Neoplasms by Histologic Type
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Thyroid Diseases
- Thyroid Neoplasms
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
- Urogenital Neoplasms
- Urologic Diseases
- Urologic Neoplasms
- Urticaria
Subsidiaries (5 direct, 6 total across the full acquisition tree)
Recent trials (50)
- NCT07266402Lead sponsorPhase 3Dec 31, 2025
- NCT07256392Lead sponsorPhase 3Nov 25, 2025
- NCT06727552Lead sponsorPhase 2Dec 31, 2024
- NCT06650761Lead sponsorPhase 1Nov 30, 2024
- NCT06455202Lead sponsorPhase 3Jul 19, 2024
- NCT06445023Lead sponsorPhase 3Jul 11, 2024
- NCT06366750Lead sponsorPhase 2Apr 12, 2024
- NCT05774184Lead sponsorPhase 2Jun 1, 2023
- NCT05788484Lead sponsorPhase 1May 11, 2023
- NCT05231122CollaboratorPhase 2Jan 15, 2023
- NCT05484011CollaboratorPhase 1Dec 31, 2022
- NCT05349890CollaboratorPhase 1Oct 15, 2022
- NCT05405660Lead sponsorPhase 2Jun 28, 2022
- NCT05368285Lead sponsorPhase 2May 19, 2022
- NCT05029999CollaboratorPhase 1Dec 31, 2021
Details
- Founded
- Hampton, NJ, US Jun 1, 1983
- Last known activity
- Dec 31, 2025